Lobular neoplasia;Néoplasies lobulaires

Annales de Pathologie

Volumn 23, Issue 6, 2003, Pages 547-553

  Sigal Zafrani, Brigitte ^a   Vincent Salomon, Anne ^a   Penault Llorca, Frédérique ^b   Sastre Garau, Xavier ^a  

^a INSTITUT CURIE   (France)

^b CENTRE JEAN PERRIN   (France)

Author keywords

Breast; Immunohistochemistry; Lobular neoplasia; Screening

Indexed keywords

BREAST CANCER; CANCER INVASION; CANCER RISK; HISTOPATHOLOGY; INVASIVE CARCINOMA; MAMMOGRAPHY; MASS SCREENING; NEEDLE BIOPSY; PHENOTYPE; REVIEW; RISK FACTOR;

BIOLOGICAL MARKERS; BIOPSY, NEEDLE; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MAMMOGRAPHY; NEOPLASM INVASIVENESS; PROGNOSIS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 1842575881     PISSN: 02426498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Schnitt SJ, Morrow M. Lobular carcinoma in situ: current concepts and controversies. Semin Diagn Pathol 1999; 16: 209-23.
2. Foote F, Stewart F. Lobular carcinoma in situ: a rare form of mammary carcinoma. Am J Pathol 1941; 17: 491-96.
3. Haagensen CD, Lane N, Lattes R, Bodian C. Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer 1978; 42: 737-69.
4. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985; 312: 146-51.
5. Page DL, Dupont WD, Rogers LW, Rados MS. Atypical hyperplastic lesions of the female breast. A longterm follow-up study. Cancer 1985; 55: 2698-708.
6. Rosen PP, Kosloff C, Lieberman PH, Adair F, Braun DW Jr. Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24 years. Am J Surg Pathol 1978; 2: 225-51.
7. Page DL, Kidd TE Jr, Dupont WD, Simpson JF, Rogers LW. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 1991; 22: 1232-9.
8. Fisher ER, Costantino J, Fisher B, Palekar AS, Paik SM, Suarez CM et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Five-year observations concerning lobular carcinoma in situ. Cancer 1996; 78: 1403-16.
9. nd edition Stanford, Connecticut: Appleton Lange; 1999.
10. Bratthauer GL, Tavassoli FA. Lobular intraepithelial neoplasia: previously unexplored aspects assessed in 775 cases and their clinical implications. Virchows Arch 2002; 440: 134-8.
11. Tavassoli FA, Millis RR, Boecker W, Lakhani SR. Lobular neoplasia. In: Tumors of the breast and female genital organs. World Health Organization Classification of tumours. Tavassoli FA, Devilee P ed. IARC press Lyon 2003: 60-64.
12. Lu Y, Osin P, Lakhani S, Di Palma S, Gusterson B, Shipley J. Comparative genomic hybridization analysis of lobular carcinoma in situ and atypical lobular hyperplasia and potential roles for gains and losses of genetic material in breast neoplasia. Cancer Res 1998; 58: 4721-7.
13. Jacobs TW, Pliss N, Kouria G, Schnitt SJ. Carcinomas in situ of the breast with indeterminate features: role of E-cadherin staining in categorization. Am J Surg Pathol 2001; 5: 229-36.
14. Acs G, Lawton TJ, Rebbeck TR, Li Volsi VA, Zhang PJ. Diffierential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications. Am J Clin Pathol 2001; 115: 85-98.
15. Goldstein NS, Bassi D, Watts JC, Layfield LJ, Yaziji H, Gown AM. E-cadherin reactivity of 95 noninvasive ductal and lobular lesions of the breast. Implications for the interpretation of problematic lesions. Am J Clin Pathol 2001; 115: 534-42.
16. Maluf HM, Swanson PE, Koerner FC. Solid lowgrade in situ carcinoma of the breast: role of associated lesions and E-cadherin in differential diagnosis. Am J Surg Pathol 2001; 25: 237-44.
17. Bratthauer GL, Moinfar F, Stamatakos MD, Mezzetti TP, Shekitka KM, Man YG et al. Combined E-cadherin and high molecular weight cytokeratin immunoprofile differentiates lobular, ductal, and hybrid mammary intraepithelial neoplasias. Hum Pathol 2002; 33: 620-7.
18. Rasbridge SA, Millis RR. Carcinoma in situ involving sclerosing adenosis: a mimic of invasive carcinoma. Histopathology 1995; 7: 269-73.
19. Damiani S, Ludvikova M, Tomasic G, Bianchi S, Gown A, Eusebi V. Myoepithelial cells and basal lamina in poorly differentiated in situ duct carcinoma of the breast. Virchows Arch 1999; 434: 227-34.
20. Wang N, Wan B, Skelly M, Frid M, Glukhova M, Koteliansky V et al. Antibodies to novel myoepithelium-associated proteins distinguish between benign lesions and carcinoma in situ from invasive carcinoma of the breast. Appl Immunohistochem 1997; 5: 141-51.
21. Nemoto T, Castillo N, Tsukada Y, Koul A, Eckhert KH Jr, Bauer RL. Lobular carcinoma in situ with microinvasion. J Surg Oncol 1998; 67: 41-6.
22. Hoda S, Prasad M, Moore A, Hoda R, Giri D. Microinvasive carcinoma of the breast: can it be diagnosed reliably and is it clinically significant? Histopathology 1999; 35: 468-72.
23. Kuroda N, Sugimoto T, Numoto S, Enzan H. Microinvasive lobular carcinoma associated with intraductal spread arising in a mammary hamartoma. J Clin Pathol 2002; 55: 76-7.
24. Prasad M, Hyjek E, Giri D, Ying L, O'Leary J, Hada S. Double immuno-labeling with cytokeratin and smooth muscle actin in confirming early invasive carcinoma of the breast. Am J Surg Pathol 1999; 23: 176-81.
25. Abner AL, Connolly JL, Recht A, Bornstein B, Nixon A, Hetelekidis S et al. The relation between the presence and extent of lobular carcinoma in situ and the risk of local recurrence for patients with infiltrating carcinoma of the breast treated with conservative surgery and radiation therapy. Cancer 2000; 88: 1072-7.
26. Page D, Schuyler PA, Dupont WD, Jensen RA, Plummer WD, Simpson JF. Atypical lobular neoplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet 2003; 361: 125-29.
27. Reis-Filho JS, Lakhani SR. The diagnosis and management of pre-invasive breast disease: genetic alterations in pre-invasive lesions. Breast Cancer Res 2003; 5: 313-9.
28. O'Driscoll D, Britton P, Bobrow L, Wishart G, Sinnatamby R, Warren R. Lobular carcinoma in situ on core biopsy. What is the clinical significance? Clinical Radiology 2001; 56: 216-20.
29. Sapino A, Frigerio A, Peterse JL, Arisio R, Coluccia C, Bussolati G. Mammographically detected in situ lobular carcinomas of the breast. Virchows Arch 2000; 436: 421-30.
30. Georgian-Smith D, Lawton TJ. Calcifications of lobular carcinoma of the breast: radiologic-pathologic correlation. Am J Roentgenol 2001; 176: 1255-9.
31. Middleton L, Grant S, Stephens T, Sneige N, Sahin A. Lobular carcinoma in situ on core needle biopsy: when should one recommend excision? Mod Pathol 2003; 16: 120-9.
32. Jacobs TW, Conolly JL, Schnitt SJ. Non malignant lesions in breast core needle biopsies. To excise or not to excise? Am J Surg Pathol 2002; 26: 1095-1110.
33. Liberman L, Sama M, Susnik B, Rosen P, La Trenta L, Morris E et al. Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings. Am J Roentgenol 1999; 173: 291-9.